Cancer Clinical Trials

247 studies are recruiting for cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

1. Young Adult Infusion Space Experience Satisfaction Survey

   The purpose of this study is to compare the satisfaction of Adolescent and Young Adults (AYA) receiving treatment in two different infusion spaces at the North Carolina Basnight Cancer Hospital (NCBCH). A survey and semi-structured interviews will be administered to participants to compare the expe…

   Stage

   Not phased

   Ages

   18 to 39

   Site

   UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

   Run by

   UNC Lineberger Comprehensive Cancer Center

   See if you can join NCT05720546 on ClinicalTrials.gov

2. Pan Tumor Rollover Study

   Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   University of Louisville-James Graham Brown Cancer Center, Louisville, Kentucky

   Locations

   410 in total

   Run by

   Bristol-Myers Squibb

   See if you can join NCT03899155 on ClinicalTrials.gov

3. Keep Social Randomized Controlled Trial for Young Adults With Cancer

   The main purpose of this Keep Social randomized controlled trial is to examine the effectiveness of our social connectedness intervention to improve social and emotional well-being among young adults with cancer. The investigators will conduct a randomized controlled trial with a sample of up to 39…

   Stage

   Not phased

   Ages

   22 to 39

   Site

   University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

   Run by

   UNC Lineberger Comprehensive Cancer Center

   See if you can join NCT07788339 on ClinicalTrials.gov

4. Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed Cancer

   This pilot study evaluates a pharmacist-led medication adherence intervention and Medisafe mobile application among patients with newly diagnosed cancer and multimorbidity. Thirty participants will be randomized to intervention or usual care to assess feasibility, acceptability, usability, and prel…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Duke University, Durham, North Carolina

   Run by

   Duke University

   See if you can join NCT07811258 on ClinicalTrials.gov

5. Cancer Experience Registry (CER) for Cancer Patients and Caregivers

   The Cancer Experience Registry®: An Online Survey Research Study to Understand the Experiences of Those Impacted By a Cancer Diagnosis. The Registry is a web-based platform to distribute cross-sectional and longitudinal surveys. Study surveys are designed based on input from advisor experts, includ…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Cancer Support Community Research & Training Institute, Washington D.C., District of Columbia

   Run by

   Cancer Support Community, Research and Training Institute, Philadelphia

   See if you can join NCT02333604 on ClinicalTrials.gov

6. Rare Tumors and Cancer Predisposition in Individuals and Families

   Background: Some people may be prone to develop cancer for many reasons. Factors that affect their risk include the genes they inherit and the environment they live and work in. Researchers want to learn more about the natural history of cancer. Objective: To understand how genes and environmental …

   Stage

   Not phased

   Ages

   1 to 99

   Site

   National Institutes of Health Clinical Center, Bethesda, Maryland

   Locations

   2 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT05350761 on ClinicalTrials.gov

7. Met Non Small Cell Cancer Registry (MOMENT)

   The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small cell lung cancer (NSCLC) treatment landscape and outcomes over time. The registry will capture data …

   Stage

   Not phased

   Ages

   Any age

   Site

   Holy Cross Health, Fort Lauderdale, Florida

   Locations

   80 in total

   Run by

   EMD Serono Research & Development Institute, Inc.

   See if you can join NCT05376891 on ClinicalTrials.gov

8. 000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

   Protocol # 000860 Background: Diffuse gliomas are tumors that affect the brain and spinal cord. Gliomas that develop in people with certain gene mutations (IDH1 or IDH2) are especially aggressive. Better treatments are needed. Objective: To see if a study drug (zotiraciclib) is effective in people …

   Stage

   Phase 1

   Ages

   15 to 99

   Site

   Mayo Clinic Flordia, Jacksonville, Florida

   Locations

   2 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT05588141 on ClinicalTrials.gov

9. Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors

   This protocol is a retrospective study using observational data to conduct a target trial emulation to examine the association of exercise on cancer specific endpoints and other clinical outcomes in cancer survivors.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York

   Locations

   3 in total

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT07030686 on ClinicalTrials.gov

10. Avera Cancer Sequencing and Analytics Protocol (ASAP)

    The purpose of this study is to characterize the breadth of molecular features present in participants receiving care within a large, integrated, community-based healthcare system. Through comprehensive genomic profiling, investigators aim to identify the underlying genomic drivers of premalignant …

    Stage

    Not phased

    Ages

    18 and older

    Site

    Avera Cancer Institute - Marshall, Marshall, Minnesota

    Locations

    6 in total

    Run by

    Avera McKennan Hospital & University Health Center

    See if you can join NCT05142033 on ClinicalTrials.gov

11. A Natural History Study of Metabolic Sizing in Health and Disease

    Background: Scientists have long used simple measures (such as height and weight) to estimate how much a person s body uses food (calories) as energy, as commonly called the metabolic rate. But metabolism varies among people with similar body sizes. Scientists now believe the old formulas for estim…

    Stage

    Not phased

    Ages

    2 to 99

    Site

    National Institutes of Health Clinical Center, Bethesda, Maryland

    Run by

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    See if you can join NCT05398783 on ClinicalTrials.gov

12. Comprehensive Care for AYA: Needs Assessment Survey

    The goal of this observational study is to assess gaps in education about exercise, sexual health, fertility, survivorship, financial issues, interpersonal relationships, and clinical trial participation among adolescents and young adults with cancer. Participants will be asked to complete a series…

    Stage

    Not phased

    Ages

    15 and older

    Site

    Atrium Health Levine Cancer, Charlotte, North Carolina

    Locations

    2 in total

    Run by

    Wake Forest University Health Sciences

    See if you can join NCT07196241 on ClinicalTrials.gov

13. Study of the Effect of Innate on the Inflammatory Response to Endotoxin

    Background: - Innate immunity is the process by which white blood cells and other parts of the immune system sense and respond to potential infections by causing an inflammation. Researchers are interested in studying how the body responds to certain environmental factors, and whether the body s re…

    Stage

    Not phased

    Ages

    18 to 100

    Site

    NIEHS Clinical Research Unit (CRU), Research Triangle Park, North Carolina

    Run by

    National Institute of Environmental Health Sciences (NIEHS)

    See if you can join NCT01143480 on ClinicalTrials.gov

14. Tumor Related Epilepsy

    Background: Some people with brain tumors have seizures related to the tumor. This is called tumor-related epilepsy. Usually brain tumors are treated by removing as much of the brain tumor as possible without causing problems. Researchers think this may improve the outcome for people with brain tum…

    Stage

    Not phased

    Ages

    8 to 99

    Site

    National Institutes of Health Clinical Center, Bethesda, Maryland

    Run by

    National Institute of Neurological Disorders and Stroke (NINDS)

    See if you can join NCT02639325 on ClinicalTrials.gov

15. Connect for Cancer Prevention Study (Connect)

    Background: The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of pe…

    Stage

    Not phased

    Ages

    30 to 70

    Site

    Kaiser Permanente Colorado, Denver, Colorado

    Locations

    10 in total

    Run by

    National Cancer Institute (NCI)

    See if you can join NCT04609072 on ClinicalTrials.gov

16. Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

    Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect and store an eligible participant's own T cells for future use to make CAR T-Cell therapy for their disease treatment. Desi…

    Stage

    Not phased

    Ages

    18 and older

    Site

    Banner Health, Gilbert, Arizona

    Locations

    16 in total

    Run by

    A2 Biotherapeutics Inc.

    See if you can join NCT04981119 on ClinicalTrials.gov

17. Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

    Determine the effects of the Computerized Symptom Assessment Tool (C-SCAT) versus usual care on the primary outcomes of self-efficacy for symptom management and symptom self-management behaviors

    Stage

    Not phased

    Ages

    15 to 29

    Site

    Children's Mercy Hospital, Kansas City, Missouri

    Locations

    5 in total

    Run by

    Virginia Commonwealth University

    See if you can join NCT05958316 on ClinicalTrials.gov

18. A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

    The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutations.

    Stage

    Phase 1

    Ages

    18 and older

    Site

    Research Site, Orlando, Florida

    Locations

    14 in total

    Run by

    Alterome Therapeutics, Inc.

    See if you can join NCT06835569 on ClinicalTrials.gov

19. Multi-Cancer Detection Observational Cohort Study

    This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.

    Stage

    Not phased

    Ages

    21 and older

    Site

    Mayo Clinic in Arizona, Scottsdale, Arizona

    Locations

    3 in total

    Run by

    Mayo Clinic

    See if you can join NCT06962995 on ClinicalTrials.gov

20. Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

    This clinical trial tests the safety, tolerability, and effectiveness of a virtual reality intervention to improve psychological symptom burden for cancer patients undergoing treatment. Virtual reality (VR) is a technology that allows users to experience and interact with three-dimensional, compute…

    Stage

    Not phased

    Ages

    18 to 90

    Site

    Mayo Clinic in Florida, Jacksonville, Florida

    Run by

    Mayo Clinic

    See if you can join NCT07221409 on ClinicalTrials.gov

21. Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

    The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the…

    Stage

    Not phased

    Ages

    18 and older

    Site

    University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico

    Run by

    New Mexico Cancer Research Alliance

    See if you can join NCT03977402 on ClinicalTrials.gov

22. ChangeGradients: Promoting Adolescent Health Behavior Change

    As most adolescents visit a healthcare provider once a year, health behavior change interventions linked to clinic-based health information technologies hold significant promise for improving healthcare quality and subsequent behavioral health outcomes for adolescents (Baird, 2014, Harris, 2017). R…

    Stage

    Not phased

    Ages

    15 to 17

    Site

    University of California San Francisco Adolescent and Young Adult Medicine Clinic, San Francisco, California

    Run by

    University of California, San Francisco

    See if you can join NCT04110756 on ClinicalTrials.gov

23. A Study in Patients Reporting Cannabis Use Followed With an Application-Based Cannabis Journal

    This study is being done because there is a significant lack of data on the use of cannabis amongst cancer patients. The investigators believe that the collection of this data will help researchers and clinicians better understand the needs and the impact of cannabis use in this specific patient po…

    Stage

    Not phased

    Ages

    18 and older

    Site

    MaineHealth Cancer Care, Scarborough, Maine

    Run by

    Scot Remick

    See if you can join NCT07089225 on ClinicalTrials.gov

24. Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

    Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

    Stage

    Phase 2

    Ages

    2 to 99

    Site

    University of California, San Francisco, San Francisco, California

    Locations

    6 in total

    Run by

    Children's Hospital of Philadelphia

    See if you can join NCT05783323 on ClinicalTrials.gov

25. Galleri® in the Medicare Population.

    This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek enrollment that is representative of the Medicare population.

    Stage

    Not phased

    Ages

    50 and older

    Site

    Mercy Health - Fort Smith, Fort Smith, Arkansas

    Locations

    72 in total

    Run by

    GRAIL, Inc.

    See if you can join NCT05673018 on ClinicalTrials.gov